Dr. Jeremiah Malerich is a Solution Consultant working in the Discovery Portfolio of Certara. He joined Chemaxon – acquired by Certara in 2025 – two years ago after a long career in the CRO business supporting drug discovery programs. In his previous life, he saw how critical robust cheminformatic tools were to the success of programs, and he now brings that experience to Certara and its partners. His background is synthetic organic chemistry with a PhD from the University of California, Berkeley.